Effect of onchocerciasis elimination measures on the incidence of epilepsy in Maridi, South Sudan

High onchocerciasis transmission predisposes endemic communities to a high epilepsy burden. The 4·4% epilepsy prevalence documented in 2018 in Maridi, South Sudan, prompted the strengthening of onchocerciasis elimination measures. Community-directed treatment with ivermectin was implemented annually in 2017, 2018, and 2019, interrupted in 2020, and re-implemented biannually in 2021. This longitudinal, prospective, population-based study, aimed to assess the effect of these interventions, along with slash and clear vector control on the incidence of epilepsy, including nodding syndrome, in eight sites near the Maridi dam.

When biannual community-directed treatment with ivermectin was initiated in 2021, the intervention's coverage rose by 15·7% although only 56·6% of the population took ivermectin in 2021. Between 2018 and 2022, epilepsy incidence decreased from 348·8 to 41·7 per 100 000 person-years. Similarly, the incidence of nodding syndrome decreased from 154·7 to 10·4 per 100 000 person-years. The identified risk factors for epilepsy were: living closer to the Maridi dam, being aged between 6 and 40 years, not taking ivermectin, and being male.

The paper concludes that in onchocerciasis-endemic areas with high epilepsy prevalence, strengthening onchocerciasis elimination interventions can decrease the incidence of epilepsy, including nodding syndrome. However additional efforts are needed to increase community-directed treatment with ivermectin coverage and sustain blackfly control in Maridi.